Hallucinogen-like actions of 5-methoxy-N,N-diisopropyltryptamine in mice and rats
by
Fantegrossi WE, Harrington AW, Kiessel CL, Eckler JR, Rabin RA,
Winter JC, Coop A, Rice KC, Woods JH.
Division of Neuroscience, Yerkes National Primate Research Center,
Emory University, 954 Gatewood Road,
Atlanta, GA 30322, USA.
[email protected]
Pharmacol Biochem Behav. 2006 Jan;83(1):122-9.

ABSTRACT

Few studies have examined the effects of 5-methoxy-N,N-diisopropyltryptamine (5-MeO-DIPT) in vivo. In these studies, 5-MeO-DIPT was tested in a drug-elicited head twitch assay in mice where it was compared to the structurally similar hallucinogen N,N-dimethyltryptamine (N,N-DMT) and challenged with the selective serotonin (5-HT)2A antagonist M100907, and in a lysergic acid diethylamide (LSD) discrimination assay in rats where its subjective effects were challenged with M100907 or the 5-HT 1A selective antagonist WAY-100635. Finally, the affinity of 5-MeO-DIPT for three distinct 5-HT receptors was determined in rat brain. 5-MeO-DIPT, but not N,N-DMT, induced the head twitch responses in the mouse, and this effect was potently antagonized by prior administration of M100907. In rats trained with LSD as a discriminative stimulus, there was an intermediate degree (75%) of generalization to 5-MeO-DIPT and a dose-dependent suppression of response rates. These interoceptive effects were abolished by M100907, but were not significantly attenuated by WAY-100635. Finally, 5-MeO-DIPT had micromolar affinity for 5-HT 2A and 5-HT 2C receptors, but much higher affinity for 5-HT 1A receptors. 5-MeO-DIPT is thus effective in two rodent models of 5-HT2 agonist activity, and has affinity at receptors relevant to hallucinogen effects. The effectiveness with which M100907 antagonizes the behavioral actions of this compound, coupled with the lack of significant antagonist effects of WAY-100635, strongly suggests that the 5-HT 2A receptor is an important site of action for 5-MeO-DIPT, despite its apparent in vitro selectivity for the 5-HT 1A receptor.

Foxy
Psilocybe
Mescaline
Kava kava
Ayahuasca
Hallucinogens
St John's wort
Foxy and the rat
Salvia Divinorum
Tryptamines.com
Fluoxetine and LSD
Psychoactive fungi
Hallucinogens and redemption
Hofmann's LSD: My Problem Child
Hallucinogen-treated blind monkeys
Religious Teatime and the High Court
Monkeys don't enjoy hallucinogens very much
Naturally-growing hallucinogens and dissociative agents
Metabolism of 5-methoxy-N,N-diisopropyltryptamine (Foxy)

HOME
HedWeb
Cocaine.org
Future Opioids
BLTC Research
Utopian Surgery?
Paradise-Engineering
The Hedonistic Imperative
MDMA: Utopian Pharmacology